Stockreport

Ultragenyx proposes to buy all Dimension Therapeutics outstanding common stock for $138 mln [MarketWatch]

DIMENSION THERAPEUTICS  (DMTX) 
US:NASDAQ Investor Relations: investors.dimensiontx.com
PDF Ultragenyx proposes to buy all Dimension Therapeutics outstanding common stock for $138 mln Ultragenyx Pharmaceutical Inc. RARE, -0.04% said early Monday that it has [Read more]